Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Acta Clinica Belgica|May 6, 2016
Normalization of mediastinal widening after successful treatment of mediastinal tuberculosisJo Raskin, Pascal Van Bleyenbergh
Journal of the Belgian Society of Radiology|June 23, 2020
Correction: A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer PatientCharlotte De Bondt, Annemiek Snoeckx, Jo Raskin
Translational Lung Cancer Research|November 14, 2025
Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic reviewIllaa Smesseim, Jo Raskin, Jacobus A Burgers
Journal of the Belgian Society of Radiology|May 8, 2020
A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progressionCharlotte De Bondt, Annemiek Snoeckx, Jo Raskin
ERJ Open Research|February 27, 2018
Do-not-resuscitate orders as part of advance care planning in patients with COPDJo Raskin, Kristina Vermeersch, Stephanie Everaerts, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 15, 2021
Recent developments in the treatment of small cell lung cancerBirgitta I Hiddinga, Jo Raskin, Annelies Janssens, et al.
Current Opinion in Oncology|November 6, 2019
Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapyJan P Van Meerbeeck, Christel De Pooter, Jo Raskin, et al.
Biomedicines|March 25, 2022
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural MesotheliomaSophie Rovers, Annelies Janssens, Jo Raskin, et al.
Translational Lung Cancer Research|November 20, 2018
A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205)Jo Raskin, Veerle Surmont, Robin Cornelissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-AnalysisJanah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.
Pageof 4